Join
Live feed
·
PRReleasevia Quantisnow
aTyr Pharma Inc. logo

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

ByQuantisnow·Wall Street's wire, on your screen.
ATYR· aTyr Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATYR (aTyr Pharma Inc.) and more on Quantisnow.